StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LNTH

Lantheus Holdings, Inc.

LNTH Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗
$101.19
+0.19 +0.19%

Key statistics

from XBRL data in SEC filings
Market cap
$6.59B
Revenue (TTM)
$1.55B
Net income (TTM)
$279M
EPS (TTM)
$4.19
P/E ratio
24.2
Dividend yield
Free cash flow
$345M
Cash
$499M
Total assets
$2.35B
Gross margin
60.5%
52-week range
$47.25 – $111.86

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure; Other events Aug 3, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results May 1, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 6, 2025 8-K Director or officer change Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Aug 6, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Jul 22, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Amended charter or bylaws; Shareholder vote results May 5, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Director or officer change Jan 30, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Jan 28, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 23, 2024 8-K Regulation FD disclosure Dec 19, 2024 8-K Other events Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Regulation FD disclosure Sep 25, 2024 8-K Director or officer change Sep 5, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Regulation FD disclosure Jun 27, 2024 8-K Director or officer change Jun 24, 2024 8-K Director or officer change May 15, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Director or officer change; Shareholder vote results Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Regulation FD disclosure Jan 26, 2024